Insiders / Thompson Peter A.

Thompson Peter A.

CIK 1357522personinsider
Companies
4
First seen
Jan 30, 2026
Last activity
Jun 26, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Sionna Therapeutics, Inc. · SIONDirector5,343,5433,559,76512
Corvus Pharmaceuticals, Inc. · CRVSDirector210,000210,00027
ARS Pharmaceuticals, Inc. · SPRYDirector30,0001
Edgewise Therapeutics, Inc. · EWTXDirector16,3771

All securities held

6 positions · latest reported per filing
CompanySecuritySharesAs of
ARS Pharmaceuticals, Inc.Stock Option (right to buy)Derivative30,000Jun 24, 2026
Corvus Pharmaceuticals, Inc.Common Stock210,000Jan 28, 2026
Corvus Pharmaceuticals, Inc.Stock Option (Right to Buy)Derivative15,000Jun 11, 2026
Edgewise Therapeutics, Inc.Stock Option (Right to Buy)Derivative16,377Jun 5, 2026
Sionna Therapeutics, Inc.Common Stock5,343,543May 27, 2026
Sionna Therapeutics, Inc.Non-Qualified Stock Option (right to buy)Derivative17,340Jun 17, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Apr 15, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$10.53M-236K
-6.77%
3,247,025
7.18% of shares
medium
Apr 16, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$10.29M-227K
-6.99%
3,020,119
6.68% of shares
medium
May 11, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$8.53M-185K
-6.46%
2,671,822
5.91% of shares
medium
May 8, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$2.66M-60K
-2.05%
2,856,461
6.32% of shares
medium
Apr 17, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$2.34M-52K
-1.73%
2,967,722
6.56% of shares
medium
May 7, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$2.17M-49K
-1.64%
2,916,228
6.45% of shares
medium
Apr 14, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$2.13M-48K
-1.35%
3,482,888
7.70% of shares
medium
Feb 3, 2026SellSION
Sionna Therapeutics, Inc.
Common Stock
$1.30M-29K
-0.82%
3,530,702
7.81% of shares
medium
Jan 28, 2026ExerciseCRVS
Corvus Pharmaceuticals, Inc.
Common Stock
$450.0K+30K
30,000
0.04% of shares
low
Jan 28, 2026ExerciseCRVS
Corvus Pharmaceuticals, Inc.
Common Stock
$187.5K+15K
+33.33%
60,000
0.07% of shares
low